Evidence map›Paper›PMID 42763331›Full record

ArticleEuropean radiology2026

Classification of histology and molecular subtypes of brain gliomas and glioneuronal and neuronal tumors using a deep learning approach.

Minghao Wu, Yuchen Sun, Dan Bao, Junjie Li, Yunyun Duan, Zhizheng Zhuo, Jinyuan Weng, Jun Qiu, Qiang Yue, Shuang Li and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Minghao Wu *Department of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Yuchen Sun *School of Medical Technology, Beijing Institute of Technology, Beijing, China.
Dan BaoDepartment of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Junjie LiDepartment of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Yunyun DuanDepartment of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Zhizheng ZhuoDepartment of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Jinyuan WengPhilips Healthcare, Shanghai, China.
Jun QiuDepartment of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Qiang YueDepartment of Radiology, West China Hospital of Sichuan University, Chengdu, China.
Shuang LiDepartment of Radiology, West China Hospital of Sichuan University, Chengdu, China.
Yinfeng QianDepartment of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Duanduan ChenSchool of Medical Technology, Beijing Institute of Technology, Beijing, China. duanduan@bit.edu.cn.
Shuaitong ZhangSchool of Medical Technology, Beijing Institute of Technology, Beijing, China. zhangshuaitong@bit.edu.cn.
Yaou LiuDepartment of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. yaouliu80@163.com.ORCID http://orcid.org/0000-0002-9930-0331

Funding

Beijing Municipal Natural Science Foundation No.7254341Beijing Natural Science Foundation No. L232132Beijing Natural Science Foundation No. L246071Capital Health Development Scientific Research Special Project of Beijing Municipal Health Commission NO.2022-1-2042Capital Medical Science Innovation Center Scientific Research Pioneering Project NO.CX23YZ01Radiation Imaging Database Project of the National Health Commission NO.YXFSC2022JJSJ004the Special Fund the Innovation and Transformation Competition of Beijing Tiantan Hospital special funding TYZH202502the Young Elite Scientist Sponsorship Program by Beijing Association for Science and Technology No. BYESS2024134Training Fund for Open Projects at Clinical Institutes and Departments of Capital Medical University No. CCMU2024ZKYXZ007
6 · The paper itself

Abstract

purposeTo develop a deep learning classification system for integrated histology and molecular subtyping of gliomas and glioneuronal/neuronal tumors (GNTs). MATERIALS AND

methodsPreoperative multi-parametric MRI data from 1,844 patients with gliomas or GNTs, encompassing T1WI, post-contrast T1WI (T1(+C)), T2Flair, T2WI, and DWI, were analyzed. Subjects were classified into six categories: (1) oligodendroglioma, IDH-mutant, and 1p/19q-codeleted; (2) astrocytoma, IDH-mutant; (3) glioblastoma, IDH-wildtype; (4) pilocytic astrocytoma (PA); (5) pleomorphic xanthoastrocytoma (PXA); and (6) GNTs. A three-level classification system (MRI-G/GNTs) using MobileNetV2 was trained and validated in internal and external datasets. Sequential forward feature selection (SFFS) was utilized to optimize multi-modal network combinations. Furthermore, the MRI-G/GNTs outputs were integrated into structured virtual pathology reports.

resultsThe average Dice for the brain tumor segmentation model was 0.92. Using SFFS, we identified optimal MRI sequence combinations per classification step. The external tests AUCs reached 0.92 for distinguishing adult-type diffuse gliomas from circumscribed astrocytic gliomas/GNTs (T1(+C), Flair, and T2WI combination), 0.92 for distinguishing IDH status for adult-type diffuse glioma (T1(+C)/Flair/ADC), 0.83 for distinguishing 1p/19q status for IDH-mutant diffuse glioma (ADC/Flair), 0.84 for circumscribed astrocytic gliomas vs GNTs (ADC/T1(+C)), 0.95 for PA vs PXA (ADC/T1(+C)/T2WI). Based on the automated prediction pipeline, the integrated classification performance of the MRI-G/GNTs system achieved AUCs of 0.92, 0.81, 0.87, 0.82, 0.94, and 0.69, with accuracy of 0.88, 0.88, 0.89, 0.81, 0.91, and 0.95 across the above six tumor categories.

conclusionsThe MRI-G/GNTs system demonstrates strong capability in distinguishing both histological and molecular subtypes of brain gliomas and GNTs. KEY POINTS: Question How about the deep learning model based on MRI for integrated histology and molecular classification of brain GNTs, and can it be improved? Findings The MRI-G/GNTs system achieved AUCs of 0.69-0.92 with accuracy of 0.81-0.95 for distinguishing six tumor categories of GNTs. Clinical relevance The three-level deep learning classification system (MRI-G/GNTs) based on optimized multimodal MRI integration firstly achieves comprehensive histology and molecular subtype classification of brain GNTs.

Indexed as

Deep learningGenotypesGliomaHistologyMagnetic resonance imaging

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.